Physician profile
Celeste Nagy
NPI 1104213073
$2,799.79
in general payments reported to CMS, 2019-2025
16 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 88% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.17 · 2022: $1,405 · 2024: $161 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280 · Education: $34.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.71 |
| Education | $34.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,617.08 | 2022-2025 | Scopis Ent, Clarifix, Xpress Loprofile |
| Medtronic, INC. | $338.30 | 2024-2025 | Ligasure, Stealthstation S8 Platform, Propel |
| Allergan, INC. | $140.86 | 2021-2022 | |
| Glaxosmithkline, LLC. | $125.75 | 2025 | Nucala |
| Vertex Pharmaceuticals Incorporated | $123.49 | 2025 | |
| Smith+Nephew, INC. | $104.81 | 2025 | Rf20000, Tula |
| Integra Lifesciences Corporation | $83.59 | 2024-2025 | Acclarent Aera, Inspira Air, Relieva Spinplus Nav |
| Depuy Synthes Sales INC. | $51.33 | 2022 | |
| Merz North America, INC. | $36.72 | 2022 | |
| Aerin Medical INC. | $34.97 | 2025 | |
| Pharmaessentia USA Corporation | $32.81 | 2024 | Besremi |
| Karyopharm Therapeutics INC. | $32.24 | 2024 | Xpovio |
| Lilly USA, LLC | $21.51 | 2025 | Jaypirca, Verzenio |
| Astrazeneca Pharmaceuticals Lp | $19.09 | 2025 | |
| Neurent Medical Limited | $18.88 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $18.36 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celeste Nagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.